NCT05992038

Brief Summary

Rationale: Realignment osteotomies around the knee are a proven surgical treatment for unicompartmental knee osteoarthritis and a malalignment. Osteotomies can be very painful in the early postoperative phase. This is probably due to a combination of bony cut (bone pain) and postoperative hematoma (bleeding and leakage of the bone marrow) in the surrounding soft tissue. The AttraX® Putty can be used as a gap filler in open wedge osteotomies to potentially reduce postoperative pain by reducing the bleeding from the bone gap. Objective: The main aim of this study is to determine whether early postoperative pain is decreased when the osteotomy gap is filled with AttraX® Putty, compared to conventional open wedge osteotomy without filling the gap. The secondary aims are faster accelerated rehabilitation/regaining function, reduction of local blood loss, accelerated bone union, comparable surgical accuracy, and the occurrence of (serious) adverse events. Study design: Single-blinded, prospective, randomized controlled trial. Study population: Adult patients qualifying for open-wedge tibial, open-wedge femur or double level osteotomy. Intervention: According to a randomization scheme, the osteotomy gap will be filled with either the synthetic ceramic material AttraX® Putty or without a gap filler (conventional method). Main study parameters/endpoints: The main study endpoint is the Numeric Rating Scale (NRS) pain during the first week postoperative. The secondary study endpoints are faster rehabilitation/regaining function, reduction of local blood loss, accelerated bone union, comparable surgical accuracy, and (serious) adverse events. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Patients may have the advantage of experiencing less pain postoperatively if they are treated with the AttraX® Putty, which can contribute to a faster rehabilitation. Risks to the AttraX® Putty group may include an allergic reaction, failure to promote bone fusion and excessive bone growth. However, the preclinical studies and clinical studies show that the use of AttraX® Putty is safe for use in humans.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Sep 2023Dec 2026

First Submitted

Initial submission to the registry

July 26, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

August 15, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

September 20, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

3 years

First QC Date

July 26, 2023

Last Update Submit

April 28, 2026

Conditions

Keywords

OsteotomyGap fillerPostoperative painRandomized controlled trialAttraX Putty

Outcome Measures

Primary Outcomes (1)

  • The mean NRS pain score

    Questionnaire to measure pain.The NRS score is a score between 0 and 10, where 0 means no pain and 10 means the most pain imaginable.

    First week postoperative daily score

Secondary Outcomes (5)

  • Rehabilitation time

    After surgery (+2 weeks, +1 months, +3 months, +6 months, +1 year)

  • Reduction of local blood loss

    Before surgery and 1 day after surgery

  • Reduction of local blood loss

    Before surgery and a weekly home measurement up to and including 1 month after surgery.

  • Union rate

    +1 months, +4 months, +6months, and +12 months

  • Postoperative NRS pain score

    After surgery (second week daily score), +1 months, +3months

Study Arms (2)

Putty

EXPERIMENTAL

The osteotomy gap will be filled with a synthetic ceramic material, Putty

Procedure: Osteotomy with putty

Conventional

PLACEBO COMPARATOR

Osteotomy performed according to the conventional method, without gap filler

Procedure: Conventional osteotomy

Interventions

Synthetic ceramic putty

Putty

conventional osteotomy

Conventional

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • indication for an open-wedge osteotomy of the femur, tibia or double level due to unicompartmental osteoarthritis (OA).
  • Comply with all aspects of the treatment, including CT scans, radiographs and 1-year follow-up
  • Informed consent

You may not qualify if:

  • Osteotomy for indication of cartilage treatment or other knee surgeries than unicompartmental OA
  • Correction using an open wedge above 10 mm
  • Pregnant women at time of enrollment or women who are planning to become pregnant during the duration of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University medical center Utrecht

Utrecht, Utrecht, 3584 CX, Netherlands

RECRUITING

Related Links

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Osteotomy

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Orthopedic ProceduresSurgical Procedures, Operative

Study Officials

  • R.J.H. Custers, Dr

    UMC Utrecht

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 26, 2023

First Posted

August 15, 2023

Study Start

September 20, 2023

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations